The relationship between senescence signalling and BRAF inhibitor resistance is best exemplified in melanoma where drug resistance is also typically accompanied by dedifferentiation markers such as NGFR, which is inducible by type II interferons (IFNγ) [5, 35, 36]. This evidence concerns the gene BRAF and melanoma.